Inventory Turnover measures how fast the company turns over its inventory within a year.
CK Life Sciences International Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.62.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CK Life Sciences International Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.44.
CK Life Sciences International Holdings (OTCPK:CKLSF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CK Life Sciences International Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CK Life Sciences International Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CK Life Sciences International Holdings Days Inventory Related Terms
CK Life Sciences International Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings Days Inventory Chart
CK Life Sciences International Holdings Annual Data
CKLSF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, CK Life Sciences International Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CK Life Sciences International Holdings Days Inventory vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings (CKLSF) has a Days Inventory of 112.64 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CK Life Sciences International Holdings and its competitors. This is near median its historical median of 121.48. Over the past decade, CK Life Sciences International Holdings' Days Inventory has ranged from 105.93 to 131.77. According to the industry distribution chart, CK Life Sciences International Holdings ranks #207 out of 640 companies in the Biotechnology industry, placing it in the top 32.3%.
Is CK Life Sciences International Holdings' Days Inventory too high?
CK Life Sciences International Holdings' current Days Inventory of 112.64 is near median its 10-year median of 121.48. Over the past 10 years, this metric has ranged from a low of 105.93 to a high of 131.77. The Biotechnology industry median Days Inventory is 184.15. CK Life Sciences International Holdings' value of 112.64 is 38.8% below this industry median. Based on the distribution chart, CK Life Sciences International Holdings ranks #207 out of 640 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #207 out of 640 companies for Days Inventory. This puts CK Life Sciences International Holdings in the upper half of its industry. The industry median Days Inventory is 184.15. CK Life Sciences International Holdings' value of 112.64 is 38.8% below this benchmark. Historically, CK Life Sciences International Holdings' own Days Inventory has ranged from 105.93 to 131.77 over the past decade. While the company's 10-year median is 121.48 vs. the industry median of 184.15, CK Life Sciences International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CK Life Sciences International Holdings's current Days Inventory of 112.64 is 38.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CK Life Sciences International Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CK Life Sciences International Holdings's current Days Inventory is 112.64, which is near median its own 10-year median of 121.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (CKLSF) has a current Days Inventory of 112.64. The stock's GF Value™ is $0.10, compared to a current price of $0.09 — trading 10% below its estimated fair value. The current Days Inventory is 112.64, which is near median its 10-year median of 121.48 and 38.8% below the Biotechnology industry median of 184.15. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CK Life Sciences International Holdings (CKLSF), the current Days Inventory is 112.64 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CK Life Sciences International Holdings (CKLSF) Overvalued in 2026?
Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued.
The current stock price of $0.09 is trading 10% below its estimated GF Value™ of $0.10.
Key valuation signals for CKLSF:
Days Inventory: 112.64 (near median its 10-year median of 121.48)
GF Value™: $0.10 vs. price of $0.09 (10% below fair value)
Industry Position: 38.8% below the Biotechnology median (#207 of 640)
No single metric tells the full story. See the CKLSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CK Life Sciences International Holdings Business Description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score
Get the complete analysis for CKLSF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CKLSF has been successfully added to your 
